Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for patients with COVID-19 in A Real-Life Setting: A Single Institute Analysis

Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for patients with COVID-19 in A Real-Life Setting: A Single Institute Analysis

ABSTRACT: Background: Recent data from clinical trials suggest that antibody cocktail therapy, which combined casirivimab and imdevimab, is linked to the reduction of the risk of hospitalization or death among high-risk patients with COVID-19. However, it remains unclear how effective the therapy i...

Full description

Bibliographic Details
Main Authors: Yasutaka Kakinoki, Kazuki Yamada, Yoko Tanino, Keiko Suzuki, Takaya Ichikawa, Naoki Suzuki, Go Asari, Ai Nakamura, Shin Kukita, Akito Uehara, Seisuke Saito, Shohei Kuroda, Hidemitsu Sakagami, Yuuki Nagashima, Kae Takahashi, Satoshi Suzuki
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Cocktail
Ronapreve
REGEN-COV
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971222000765

Internet

http://www.sciencedirect.com/science/article/pii/S1201971222000765

Similar Items